Navigation Links
Air Methods Petitions NTSB for Reconsideration of Probable Cause Determination
Date:6/29/2009

DENVER, June 29 /PRNewswire-FirstCall/ -- Air Methods Corporation (Nasdaq: AIRM), the largest air medical transportation company in the world, announced today it has filed a petition with the National Transportation Safety Board (NTSB) requesting the Board reconsider/modify its probable cause determination related to the June 29, 2008 mid-air collision accident in Flagstaff, Arizona. The NTSB Probable Cause Report states that "both pilots failed to see and avoid the other helicopter on approach to the helipad".

Specifically, Air Methods' petition seeks the following of the NTSB [Board]:

  1. Reconsideration and deletion of the Board's finding that a contributing cause in the accident was "the failure of Air Methods' pilot to follow arrival and noise abatement guidelines;"
  2. The addition, as a contributing cause, the presence of prescription pain-killing medication in the Classic pilot's blood that could influence decisions or performance; and
  3. The addition, as a contributing cause, of the failure of the Classic communications center to communicate pertinent information to the Classic aircraft regarding the fact that Air Methods' aircraft was inbound to Flagstaff Medical Center (FMC) with the same estimated time of arrival as the Classic aircraft.

Aaron Todd, CEO, stated, "Air Methods has filed a petition with the NTSB requesting that the Board reconsider/modify the probable cause/contributing cause determination of this accident. We are deeply troubled by what we consider to be critical inaccuracies in the NTSB current Probable Cause Report and the inconsistencies between the findings in this case versus previous cases."

Air Methods Corporation (www.airmethods.com) is a leader in emergency air medical transportation and medical services. The Hospital-Based Services Division is the largest provider of air medical transport services for hospitals. The Community-Based Services Division is the largest community-based provider of air medical services. The Products Division specializes in the design and manufacture of aeromedical and aerospace technology. The Company's fleet of owned, leased or maintained aircraft features over 300 helicopters and fixed wing aircraft.

Forward Looking Statements: This news release includes certain forward-looking statements, which are subject to various risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors, including but not limited to the size, structure and growth of the Company's air medical services and products markets; the collection rates for patient transports; the continuation and/or renewal of air medical service contracts; the acquisition of profitable Products Division contracts and other flight service operations; the successful expansion of the community-based operations; and other matters set forth in the Company's public filings.

CONTACTS: Aaron D. Todd, Chief Executive Officer, (303) 792-7413. Please contact Christine Clarke at (303) 792-7579 to be included on the Company's fax and/or mailing list.


'/>"/>
SOURCE Air Methods Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Major New Report Establishes Effective Methods of Enhancing and Preserving Brain Power as We Age
2. Air Methods Expands Community-Based Operations Into Eastern Oklahoma
3. Prominent Farmington Hills Plastic Surgeon Suggests Methods to Repair Skin Damaged by Sun Exposure
4. New Methods Could Speed Production of Flu Vaccines
5. Webcast Alert: Air Methods to Announce First Quarter 2009 Financial Results
6. Long Term Care Alerting Methods Revealed by Industry Leaders
7. Air Methods Preliminary 1st Qtr. Results Exceed Expectations
8. Air Methods Announces Year 2008 Financial Results and Provides First Quarter 2009 Update
9. Air Methods to Report Fourth Quarter and Fiscal Year 2008 Financial Results on Tuesday, March 10, 2009
10. Frost & Sullivan: Novel Diagnostics Methods Driving the European Cancer IVD Market Towards Early Detection and Prevention
11. Early Detection Methods for Pancreatic Cancer Urgently Needed: A Statement From the Pancreatic Cancer Action Network
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... ... March 27, 2017 , ... The Anaheim Hills office ... First National Capital has added 10 new sales professionals over the past 6 months ... by 15 additional new hires over the course of 2017. , “This new ...
(Date:3/27/2017)... Orange, Texas (PRWEB) , ... March 27, 2017 ... ... celebration at the GTEC Orange facility from 8:00am-10:00am on Monday, April 3rd to ... giveaways and will be an opportunity for area-residents to celebrate two great years ...
(Date:3/26/2017)... ... March 26, 2017 , ... Local physician Dr. Justin ... a prestigious award honoring the top influencers on RealSelf—the most trusted online destination ... doctors and clinics. , In 2016, more than 82 million people visited RealSelf ...
(Date:3/24/2017)... ... March 24, 2017 , ... Vighter ... the same time by providing Prehospital Trauma Life Support (PHTLS) course scholarships to ... premier prehospital trauma education developed in cooperation with the American College of Surgeons ...
(Date:3/24/2017)... ... ... The Radiology Business Management Association (RBMA) has named the nine winners ... year, are among the most prestigious in radiology marketing because a panel of radiology ... recognize achievements in both large budget (over $5,000) and small budget (under $5,000) campaigns. ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... BOSTON , March 27, 2017 ... pharmaceutical company and Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), ... commercialization of innovative therapies based upon tetracycline chemistry, ... sarecycline for the treatment of moderate to severe ... Sarecycline is a once-daily, oral, narrow spectrum tetracycline-derived ...
(Date:3/27/2017)... 2017  Impax Laboratories, Inc. (NASDAQ: IPXL)today announced that ... Bisaro as Impax,s President and Chief Executive Officer ... 27, 2017. Mr. Bisaro will succeed J. Kevin ... Chief Executive Officer since December of 2016. ... experience, Mr. Bisaro, 56, is an accomplished global business ...
(Date:3/27/2017)... 27, 2017  PhaseRx, Inc. (NASDAQ: PZRX), a ... liver diseases in children, today reported financial results ... December 31, 2016 and provided an update on ... to make progress during the fourth quarter of ... our non-human primate safety study, and with our lead ...
Breaking Medicine Technology: